Aksh Optifibre share news, announcements and annual reports
NSE: AKSHOPTFBRBSE: 532351Telecom - Equipment & AccessoriesSmall Cap
Aksh Optifibre Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2000
Last close ₹6.92down ₹0.25 (3.49%)BSE ₹6.97
Share price at the NSE close on 30 Oct 2026. Previous close ₹7.17.
30 Oct: open ₹7.20, high ₹7.20, low ₹6.83
52-week range of traded prices to 30 Oct 2026
₹3.82Low, 30 Mar 2026₹9.01High, 10 Sep 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹113 Cr2,957th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Assets held for saleon the latest balance sheet
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them.
- Assets held for saleon the latest balance sheet
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Assets held for saleon the latest balance sheet
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,86,015
Aksh Optifibre shareholding disclosures
118 filed, newest first. Page 3 of 3.
Oct 2009
7 Oct · Disclosure
Mrs. Seema Choudhari, a shareholder in the promoter group, has sold 140,834 equity shares of the Company between September 30, 2009 & October 01, 2009. Therefore, her shareholding after the above transaction is 16 equity shares of the Company.
Sep 2009
30 Sep · Disclosure
Mrs. Seema Choudhari, a shareholder in the promoter group, has sold 210,000 equity shares of the Company between September 24, 2009 & September 25, 2009. Therefore, her shareholding after the above transaction is 140,850 equity shares aggregating to 0.24% of the total issued, subscribed and paid-up equity share capital of Company.8 Sep · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company, has sold 166,000 equity shares of the Company between August 24, 2009 to August 27, 2009 (both days inclusive). Therefore, his shareholding after the above transaction is 7016434 equity shares aggregating to 11.90% of the total issued, subscribed and paid-up equity share capital of Company.
Aug 2009
21 Aug · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company, has sold 144,995 equity shares of the Company between August 13, 2009 to August 18, 2009 (both days inclusive). Therefore, his shareholding after the above transaction is 7182434 equity shares aggregating to 12.18% of the total issued, subscribed and paid-up equity share capital of Company.12 Aug · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company, has sold 144,995 equity shares of the Company between August 03, 2009 to August 07, 2009 (both days inclusive). Therefore, his shareholding after the above transaction is 7258031 equity shares aggregating to 12.31% of the total issued, subscribed and paid-up equity share capital of Company.5 Aug · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company, has sold 129,600 equity shares of the Company between July 27, 2009 & July 30, 2009 (both days inclusive). Therefore, his shareholding after the above transaction is 7403026 equity shares aggregating to 12.55% of the total issued, subscribed and paid-up equity share capital of Company.
Jun 2009
8 Jun · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company, has sold 208,462 equity shares of the Company between June 01,2009 to June 05,2009 (both days inclusive). Therefore, his shareholding after the above transaction is 7543444 equity shares aggregating to 12.792% of the total issued, subscribed and paid-up equity share capital of the Company.
Mar 2009
23 Mar · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has purchased 230,000 equity shares of the Company between March 09, 2009 to March 13, 2009 (both days inclusive). Therefore, his shareholding after the above transaction is 7751906 equity shares aggregating to 13.146% of the total issued, subscribed and paid-up equity share capital of Company
Feb 2009
10 Feb · Disclosure
Disclosure pursuant to Regulation 8A(4) of the SEBI Substantial Acquisition of Shares and Takeovers (Amendment) Regulations, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
29 Jan · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has purchased 200,000 equity shares of the Company between 22nd December 2008 to 23rd January, 2009 (both days inclusive). Therefore, his shareholding after the above transaction is 7521906 equity shares aggregating to 12.756% of the total issued, subscribed and paid-up equity share capital of Company
Mar 2008
19 Mar · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has purchased 43,500 equity shares of the Company between 4th March, 2008 to 7th March, 2008 (both days inclusive). Therefore, his shareholding after the above transaction is 6,921,906 equity shares aggregating to 12.025% of the total issued, subscribed and paid-up equity share capital of Company14 Mar · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has purchased 92824 equity shares of the Company between 25th February, 2008 to 3rd March, 2008 (both days inclusive). Therefore, his shareholding after the above transaction is 6,878,406 equity shares aggregating to 11.95% of the total issued, subscribed and paid-up equity share capital of Company
Feb 2008
28 Feb · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has purchased 167,635 equity shares of the Company between February 19, 2008 - February 22, 2008 (both days inclusive). Therefore, his shareholding after the above transaction is 6,785,582 equity shares aggregating to 11.79% of the total issued, subscribed and paid-up equity share capital of Company26 Feb · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has purchased 57097 equity shares of the Company between February 11, 2008 - February 15, 2008 (both days inclusive). Therefore, his shareholding after the above transaction is 6,617,947 equity shares aggregating to 11.50% of the total issued, subscribed and paid-up equity share capital of Company
Oct 2007
15 Oct · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has sold 5,00,000 equity shares of the Company on 08th October, 2007. Therefore, his shareholding after the above transaction is 6,560,850 equity shares aggregating to 15.27% of the total issued, subscribed and paid-up equity share capital of Company11 Oct · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has sold 352,265 equity shares of the Company between 27th September, 2007 to 1st October, 2007 (both days inclusive). Therefore, his shareholding after the above transaction is 7,060,850 equity shares aggregating to 16.43% of the total issued, subscribed and paid-up equity share capital of Company3 Oct · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has sold 370,000 equity shares of the Company between 13th September, 2007 to 2oth September, 2007 (both days inclusive). Therefore, his shareholding after the above transaction is 7,413,115 equity shares aggregating to 17.25% of the total issued, subscribed and paid-up equity share capital of Company
Aug 2007
27 Aug · Disclosure
Dr. Kailash S. Choudhari, Managing Director, of the Company has sold 370,000 equity shares of the Company between 7th August 2007 to 21st August 2007 (both days inclusive). Therefore, his shareholding after the above transaction is 7,662,115 equity shares aggregating to 17.83% of the total issued, subscribed and paid-up equity share capital of Company